Pharmacy chains sue Bausch Health, other drugmakers for overcharging for diabetes drug

Reuters

Tue, Dec 3, 2019, 6:34 AM

In this article:

Dec 3 (Reuters) - Three pharmacy chains, including Walgreens Boots Alliance, have filed a lawsuit against drugmakers Bausch Health Inc, Assertio Therapeutics and Lupin Ltd, seeking damages for overcharging for Bausch's diabetes drug Glumetza.

The lawsuit, filed on Monday, alleges that Assertio and Lupin struck a deal with units of Bausch to delay the entry of their generic versions of Glumetza and allowed the companies to "maintain a monopoly" in the sale of the branded drug and its generic copies.

Bausch, Assertio and Lupin did not immediately respond to Reuters' request for comment.

Albertson Companies Inc and Kroger Inc were among the other defendants.

(Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)

The Headache at the End of the Costco Gold Rush
Costco made buying a gold bar as simple as tossing it in a shopping cart. Adam Xi, 33 years old, called five different dealers to get a price he could accept for the gold bar he bought at Costco in October. Costco shoppers are spending as much as $200 million monthly on gold, according to a Wells Fargo estimate.
The Wall Street Journal•5h ago
Super Micro Stock Dives as It Skips Preannouncement for Earnings
In seven of the past eight quarters, the company disclosed preliminary results ahead of its earnings report, generally raising its guidance.
Barrons.com•1h ago
Super Micro Drops Near Two-Month Low on Earnings Concerns
(Bloomberg) -- Super Micro Computer Inc. shares are seeing their biggest drop in about two months on Friday, after the maker of servers announced the date of its third-quarter results but didn’t pre-announce results.Most Read from BloombergElon Wants His Money BackDubai Grinds to Standstill as Flooding Hits CityNew York’s Rich Get Creative to Flee State Taxes. Auditors Are On to ThemIsrael Reported to Have Launched Retaliatory Strike on IranRecord Rainfall in Dubai? Blame Climate Change, Not Clo
Bloomberg•2h ago
Don't buy the dip in stocks just yet as a wave of selling is about to bring the market to a bottom, according to one of the biggest bulls on Wall Street
The S&P 500 could bottom out in the next month, according to Fundstrat's head of research Tom Lee.
Business Insider•16h ago
Time to Pounce: 2 Superb Utility Stocks That Haven't Been This Cheap in at Least 10 Years
One of the fastest-growing utility stocks, along with "Wall Street's Greatest Dividend Stock," make for phenomenal buys right now.
Motley Fool•7h ago
Nvidia Falls Below Key Level Of Support; Is Nvidia A Buy Now?
If you are still holding to Nvidia stock, here is a key sell signal to watch for: Shares dipped below the 50-day moving average Friday. Nvidia's chart shows that its relative strength line, which compares the company's stock performance to the S&P 500, is flattening. Chief Executive Jensen Huang recently addressed students at his alma mater of Oregon State University and stated that "artificial intelligence is the technology industry's single greatest contribution to social elevation."
Investor's Business Daily•2h ago
Prediction: This Artificial Intelligence (AI) Stock Could Be Worth More Than Microsoft 5 Years From Now
Microsoft has been one of the pioneers in the field of AI, but this tech giant is also set to win big time from the growing adoption of this technology.
Motley Fool•4h ago
Supermicro Stock Falls Sharply, Continuing Recent Slide
Is the shine starting to come off Super Micro Computer stock? Shares of the server maker, better known as Supermicro, fell 16% Friday , putting the stock on track for its fifth decline in six sessions.
The Wall Street Journal•2h ago
Want to Outperform 88% of Professional Fund Managers? Buy This 1 Investment and Hold It Forever.
You don't have to be a stock market genius to outperform most pros.
Motley Fool•17h ago
Jamie Dimon Knew Subprime 'Could Go Up In Smoke'; Now He's Worried About An Artificial Economy 'Fueled by Government Deficit Spending'
In the chaos of the 2008 recession, perhaps no bank stood more prepared than Jamie Dimon's J.P Morgan Chase & Co. (NYSE:JPM). In advance of the crisis, Jamie Dimon realized that "underwriting standards were deteriorating across the industry," with late payments on subprime loans rising. In late 2006, the bank led his firm to exit Wall Street's hot subprime business, starting with a frantic call made to J.P. Morgan's vacationing Chief of Securitized Products where he said, "I really want you to w
Benzinga•1d ago

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Pharmacy chains sue Bausch Health, other drugmakers for overcharging for diabetes drug

Recommended Stories

The Headache at the End of the Costco Gold Rush

Super Micro Stock Dives as It Skips Preannouncement for Earnings

Super Micro Drops Near Two-Month Low on Earnings Concerns

Don't buy the dip in stocks just yet as a wave of selling is about to bring the market to a bottom, according to one of the biggest bulls on Wall Street

Time to Pounce: 2 Superb Utility Stocks That Haven't Been This Cheap in at Least 10 Years

Nvidia Falls Below Key Level Of Support; Is Nvidia A Buy Now?

Prediction: This Artificial Intelligence (AI) Stock Could Be Worth More Than Microsoft 5 Years From Now

Supermicro Stock Falls Sharply, Continuing Recent Slide

Want to Outperform 88% of Professional Fund Managers? Buy This 1 Investment and Hold It Forever.

Jamie Dimon Knew Subprime 'Could Go Up In Smoke'; Now He's Worried About An Artificial Economy 'Fueled by Government Deficit Spending'